About
Alzheimer's Treatments
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalSmall Molecule Pharmaceutical
Team (33)
Clinical Trials (18)
View allTotal Trials
18
As Lead Sponsor
15
As Collaborator
3
Total Enrollment
3,915
By Phase
EARLY_PHASE1: 3PHASE2: 7PHASE1/PHASE2: 2PHASE3: 2PHASE1: 2PHASE2/PHASE3: 1
By Status
RECRUITING: 6COMPLETED: 6TERMINATED: 2ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1UNKNOWN: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06891703Lead Sponsor
[18F]ACI-15916 PET in α-synucleinopathies
EARLY_PHASE1Recruiting
46 participants
Started: Mar 20, 2025 · Completed: Mar 31, 2026
NCT06891716Lead Sponsor
[18F]ACI-19626 PET in TDP-43 Proteinopathies
EARLY_PHASE1Recruiting
45 participants
Started: Jan 21, 2025 · Completed: Nov 30, 2026
NCT06015841Lead Sponsor
A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson's Disease
PHASE2Recruiting
150 participants
Started: Jul 24, 2023 · Completed: Jan 31, 2028
NCT05462106Lead Sponsor
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
PHASE1/PHASE2Recruiting
140 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2026
NCT05201638Lead Sponsor
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
PHASE3Recruiting
1,050 participants
Started: Jan 12, 2022 · Completed: Oct 31, 2032
Locations (1)
Headquarters
Lausanne, Switzerland
Map
Loading map...